{"createdAt":"8/2/2020, 2:08:04 PM","timestamp":1596391684373,"Company ID number":"349","DMX_ISSUER_NAME":"China Reform Health Management and Services Group Co., Ltd.","DMX_ISSUER_ID":"IID000000002148577","Country of Classification":"CHINA","name":"China Reform Health Management and Services Group Co Ltd ","code":"000503","stock_exchange":"Shenzhen Stock Exchange","people":[{"id":"国新健康保障服务集团股份有限公司_贾岩燕","group":"board","name":"贾岩燕","title":"董事长,董事","isMale":true,"age":"73","degree":"本科","salary":"32.50万","stockAmount":"-","description":"贾岩燕,男,1947年11月出生,经济学学士。曾任北京市礼花厂厂长,北京市工艺美术品总公司总经理,海南省开发建设总公司总经理兼党委书记,现任海虹企业(控股)股份有限公司董事、董事长。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_李永华","group":"board","name":"李永华","title":"董事","isMale":true,"age":"45","degree":"硕士","salary":"24.00万","stockAmount":"-","description":"李永华,男,出生于1975年,中共党员,硕士。曾任山东省东明县人民检察院公务员,汉王科技股份有限公司法律部法务总监,大唐电信科技产业控股有限公司法律事务部副总经理,电信科学技术研究院副总法律顾问,大唐电信科技产业控股有限公司法律事务部总经理,电信科学技术研究院总法律顾问,大唐电信科技产业控股有限公司副总裁、总法律顾问兼运营管理部总经理,大唐移动通信设备有限公司董事长,大唐联诚信息系统技术有限公司执行董事,中芯国际集成电路制造有限公司替任董事、大唐电信科技股份有限公司董事、党委书记兼总经理、大唐恩智浦半导体有限公司董事长、瓴盛科技(贵州)有限公司董事、上海立可芯半导体科技有限公司董事、辰芯科技有限公司董事。","lastUpdated":"2019-10-17"},{"id":"国新健康保障服务集团股份有限公司_刘英杰","group":"board","name":"刘英杰","title":"董事","isMale":true,"age":"48","degree":"博士","salary":"139.2万","stockAmount":"-","description":"刘英杰,男,生于1972年11月,中共党员,华中科技大学本科,中欧国际工商学院EMBA,北京大学软件工程博士(在读)。曾任惠普中国区服务业务总监、美国优利公司北亚区战略业务总监、中软国际总公司执委会委员、高级副总裁。现任海虹企业(控股)股份有限公司首席运营官。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_姜开宏","group":"board","name":"姜开宏","title":"董事","isMale":true,"age":"43","degree":"博士","salary":"0.00","stockAmount":"-","description":"姜开宏,男,生于1977年4月,管理学博士。现任中国国新基金管理有限公司副总经理。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_张灵","group":"board","name":"张灵","title":"董事","isMale":false,"age":"51","degree":"硕士","salary":"0.00","stockAmount":"-","description":"张灵,女,生于1969年8月,1991年毕业于天津大学精密仪器系,学士,2000年毕业于北京大学光华管理学院,硕士。曾就职于北京首都创业集团、中国信达资产管理股份公司,从事并购重组及企业改制工作,在安信证券、华融证券负责并购融资业务。主持完成大型企业资产债务重组及产业链整合、上市公司并购重组及借壳上市等项目。曾任铜陵有色金属集团等公司董事。现任国新风险投资管理(深圳)有限公司董事总经理,中海恒实业发展有限公司董事兼总经理。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_杨殿中","group":"board","name":"杨殿中","title":"董事","isMale":true,"age":"59","degree":"博士","salary":"50.08万","stockAmount":"-","description":"杨殿中,男,出生于1961年,中共党员,毕业于东北财经大学,博士研究生。曾任国新宜康投资(北京)有限公司执行董事、总经理。现任中国华星集团有限公司执行董事、总经理、党委书记,国新盛康投资基金(北京)有限公司执行董事、总经理,国新宏盛投资(北京)有限公司执行董事、总经理,中国国新资产管理有限公司常务副总经理,国新健康保障服务集团股份有限公司党委书记。","lastUpdated":"2019-10-17"},{"id":"国新健康保障服务集团股份有限公司_黄安鹏","group":"board","name":"黄安鹏","title":"独立董事","isMale":true,"age":"46","degree":"","salary":"12.00万","stockAmount":"-","description":"黄安鹏,男,生于1974年12月,毕业于北京大学。现任北京大学信息科学技术学院副教授、中国卫生信息与健康医疗大数据学会副秘书长,国家健康医疗大数据责任专家,国家健康保障重大工程专家组专家,主动健康与人口老龄化科技应对国家重点专项责任专家,国家健康产业战略规划专家。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_王秀丽","group":"board","name":"王秀丽","title":"独立董事","isMale":false,"age":"55","degree":"博士","salary":"12.00万","stockAmount":"-","description":"王秀丽女士,1965年出生,中国国籍,无境外永久居留权,对外经济贸易大学,国际贸易专业企业管理方向博士。自1988年7月至今历任对外经济贸易大学国际商学院教授;王秀丽女士拥有中国注册会计师资格证。自2015年12月至今担任三只松鼠股份有限公司独立董事。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_钱庆文","group":"board","name":"钱庆文","title":"独立董事","isMale":true,"age":"60","degree":"博士","salary":"12.00万","stockAmount":"-","description":"钱庆文,男,1960年出生,中国台湾,医疗及医院管理学博士。曾任中国台湾阳明大学医务管理研究所所长、中国台湾埔里等三家基督教医院执行董事、中国台湾卫生福利部属医院及社会福利机构管理委员、美国St.Louis公共卫生研究所兼任副教授、山东大学医学院兼任博导、国务院深化医药卫生体制改革领导小组专家委员,现就职于清华大学医院管理研究院教授、美国JohnsHopkinsUniversity公共卫生学院兼任教授。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_赵观甫","group":"supervisoryCommittee","name":"赵观甫","title":"监事会召集人","isMale":true,"age":"55","degree":"","salary":"0.00","stockAmount":"-","description":"赵观甫,男,1965年10月出生,毕业于清华大学经管学院,高级经济师,曾在中国建设银行总行信贷、办公室、个人金融、审计、投资托管等部门和建信金融投资公司工作30年,先后担任建行总行个人金融业务部副总经理、审计部总经理、投资托管部总经理、建信金融投资公司监事长,中国基金业协会兼职副会长、托管委员会主席等职务,有丰富的投资和风控相关的工作经验。现任国新风险投资管理(深圳)有限公司首席风险官。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_张旭","group":"supervisoryCommittee","name":"张旭","title":"监事","isMale":true,"age":"38","degree":"硕士","salary":"0.00","stockAmount":"-","description":"张旭,男,1982年5月出生,毕业于外交学院,法学硕士,曾任中国国新控股有限责任公司基金管理部高级经理,现任中国国新基金管理有限公司综合业务部执行董事。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_夏坤","group":"supervisoryCommittee","name":"夏坤","title":"职工监事","isMale":false,"age":"33","degree":"本科","salary":"23.06万","stockAmount":"-","description":"夏坤,女,出生于1987年,中共党员,毕业于大连理工大学,本科学历。曾任北京开创联合科技有限公司法务,现任国新健康法务部经理。","lastUpdated":"2019-09-16"},{"id":"国新健康保障服务集团股份有限公司_李永华","group":"manager","name":"李永华","title":"总裁","isMale":true,"age":"45","degree":"硕士","salary":"24.00万","stockAmount":"-","description":"李永华,男,出生于1975年,中共党员,硕士。曾任山东省东明县人民检察院公务员,汉王科技股份有限公司法律部法务总监,大唐电信科技产业控股有限公司法律事务部副总经理,电信科学技术研究院副总法律顾问,大唐电信科技产业控股有限公司法律事务部总经理,电信科学技术研究院总法律顾问,大唐电信科技产业控股有限公司副总裁、总法律顾问兼运营管理部总经理,大唐移动通信设备有限公司董事长,大唐联诚信息系统技术有限公司执行董事,中芯国际集成电路制造有限公司替任董事、大唐电信科技股份有限公司董事、党委书记兼总经理、大唐恩智浦半导体有限公司董事长、瓴盛科技(贵州)有限公司董事、上海立可芯半导体科技有限公司董事、辰芯科技有限公司董事。","lastUpdated":"2019-10-17"},{"id":"国新健康保障服务集团股份有限公司_肖琴","group":"manager","name":"肖琴","title":"董事会秘书","isMale":false,"age":"43","degree":"硕士","salary":"55.72万","stockAmount":"-","description":"肖琴,女,生于1977年3月,经济法硕士,海虹企业(控股)股份有限公司投资与证券事务部的证券事务代表,现任海虹企业(控股)股份有限公司董事会秘书。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_刘英杰","group":"manager","name":"刘英杰","title":"副总裁","isMale":true,"age":"48","degree":"博士","salary":"139.2万","stockAmount":"-","description":"刘英杰,男,生于1972年11月,中共党员,华中科技大学本科,中欧国际工商学院EMBA,北京大学软件工程博士(在读)。曾任惠普中国区服务业务总监、美国优利公司北亚区战略业务总监、中软国际总公司执委会委员、高级副总裁。现任海虹企业(控股)股份有限公司首席运营官。","lastUpdated":"2018-05-17"},{"id":"国新健康保障服务集团股份有限公司_孙立群","group":"manager","name":"孙立群","title":"副总裁","isMale":false,"age":"53","degree":"硕士","salary":"52.57万","stockAmount":"-","description":"孙立群,女,出生于1967年,中共党员,研究生学历。曾长期在政府部门从事医疗保险管理工作,曾任国新健康保障服务集团股份有限公司职工代表监事,现任国新健康研究院(筹)负责人。","lastUpdated":"2019-09-16"},{"id":"国新健康保障服务集团股份有限公司_孙迪草","group":"manager","name":"孙迪草","title":"副总裁","isMale":true,"age":"57","degree":"大专","salary":"80.00万","stockAmount":"-","description":"孙迪草,男,出生于1963年,中共党员,大专学历。现任广东海虹药通电子商务有限公司总经理,广州中公网医疗信息科技有限公司总经理,国新健康保障服务集团股份有限公司华南大区总裁。","lastUpdated":"2019-09-16"},{"id":"国新健康保障服务集团股份有限公司_沈治国","group":"manager","name":"沈治国","title":"财务负责人","isMale":true,"age":"43","degree":"硕士","salary":"15.00万","stockAmount":"-","description":"沈治国,男,出生于1977年,中共党员,毕业于清华大学,硕士。曾任工业和信息化部电信研究院财务部副主任,中广核核电运营有限公司经营财务高级业务经理、中国广核新能源控股有限公司预算管理高级业务经理、获新能源山东分公司、辽宁分公司分管财务负责人职务授权,现任中国国新控股有限责任公司财务部资深经理。","lastUpdated":"2019-09-16"}],"companyName":"国新健康保障服务集团股份有限公司","province":"海南省","englishName":"China Reform Health Mgmt&Ser Grp Co Ltd","industry":"医药生物 — 医疗服务Ⅱ","website":"www.crhms.cn","mainBusiness":"医药电子商务、医疗福利管理等","productsName":["药品及医疗器械招标代理","健康保障服务","医保基金综合管理服务业务","医疗质量安全服务业务","药械监管服务业务"],"actualController":"国务院国有资产监督管理委员会","actualControllerSharePercentage":"9.25%","registeredCapital":"8.99亿元","employeeAmount":"1157","phone":"86-010-57825201","location":"海南省海口市龙华区文华路18号君华海逸大酒店(原文华大酒店)七层","chineseDescription":"国新健康保障服务集团股份有限公司目前的主要业务领域集中在医药电子商务、医疗福利管理等方面.公司下属联众世界是世界最大的游戏网站,并和全球软件霸主微软公司展开合作,成为MSN游戏频道的合作伙伴。公司是唯一一家获得医药电子商务牌照的公司,也是国内政府采购唯一指定的电子商务公司。公司医药电子商务成交金额达到数百亿,是我国医药电子商务绝对龙头企业.公司发展战略是:坚持以资产管理为核心,以控股、参股性经营为手段,实现规模扩张和高速发展,发展成为跨行业、跨地域、综合性、多元化的大型投资及资产管理集团。","foundedDate":"1987-08-28","goPublicDate":"1992-11-30","companyHistory":"国新健康保障服务集团股份有限公司(原名:海虹企业(控股)股份有限公司（以下简称“公司”或“本公司”)）原为海南化学纤维厂，系1986年4月经海南省工商行政管理局批准成立的国有企业，1991年9月经海南省人民政府办公厅琼函（1991）86号文批准，改组为“海南化纤工业股份有限公司”。公司的企业法人营业执照注册号：460000000134920，并于1992年11月30日在深圳证券交易所上市，证券代码：000503。\n　　经过历年的派送红股、配售新股、转增股本及增发新股，截至2019年12月31日，本公司累计发行股本总数898,822,204股，注册资本为898,822,204.00元，注册地址及总部地址：海口市文华路18号君华海逸酒店703室，法定代表人：贾岩燕。母公司为中海恒实业发展有限公司，公司最终实际控制人为中国国新控股有限责任公司。收起▲","shareholders":[{"organizationId":"00000832","holderName":"中海恒实业发展有限公司","totalShare":"2.36亿","sharePercentage":"26.22%"},{"organizationId":"T003942110","holderName":"德清庆弘投资管理有限公司","totalShare":"902.11万","sharePercentage":"1.00%"},{"organizationId":"T000125370","holderName":"香港中央结算有限公司","totalShare":"689.97万","sharePercentage":"0.77%"},{"organizationId":"","holderName":"李晓飞","totalShare":"357.58万","sharePercentage":"0.40%"},{"organizationId":"","holderName":"王建林","totalShare":"334.13万","sharePercentage":"0.37%"},{"organizationId":"","holderName":"黄百询","totalShare":"327.54万","sharePercentage":"0.36%"},{"organizationId":"","holderName":"刘荣赠","totalShare":"300.00万","sharePercentage":"0.33%"},{"organizationId":"","holderName":"马如仁","totalShare":"289.00万","sharePercentage":"0.32%"},{"organizationId":"","holderName":"于志坚","totalShare":"276.37万","sharePercentage":"0.31%"},{"organizationId":"","holderName":"姜渭滨","totalShare":"273.24万","sharePercentage":"0.30%"}],"englishDescription":"China Reform Health Management and Services Group Co., Ltd., formerly SEARAINBOW HOLDING CORP., is a China-based provider of medical security services. The Company mainly provides five services. The Medicare fund comprehensive management services include Medicare fee control, Diagnosis Related Groups (DRGs) fund settlement and Medicare payment standard businesses. The health care big data services provide health record, health checkup, medical anti-fraud and auxiliary industrial upgrading services. The pharmacy benefit management (PBM) services provide procurement services based on Medicare-guaranteed payments and special patient groups, home delivery services and Medicare drugs monopoly services. The third-party administrator (TPA) services mainly provide commercial health insurances. The medical artificial intelligence services provide physicians with clinical assistance, personal medical guidance, life cycle health management and medicine and security optimization services.","englishIndustry":"Business Services","Price to earnings (ttm)":"--","Price to sales (ttm)":"90.16","Price to book (mrq)":"10.15","Price to cash flow (ttm)":"--","Total debt to equity (mrq)":"0.00","Lt debt to equity (mrq)":"0.00","Return on investment (ttm)":"-0.47","Return on equity (ttm)":"-0.45","Income statement":{"Revenue":"129.91","Total revenue":"129.91","Cost of revenue, total":"163.32","Gross profit":"(33.40)","Selling/general/admin. expenses, total":"130.38","Research & development":"5.80","Depreciation/amortization":"7.32","Interest exp.(inc.),net-operating, total":"(10.64)","Unusual expense (income)":"(33.83)","Other operating expenses, total":"(148.36)","Total operating expense":"113.99","Operating income":"15.93","Other, net":"0.07","Net income before taxes":"16.00","Provision for income taxes":"0.51","Net income after taxes":"15.49","Minority interest":"1.93","Net income before extra. items":"17.43","Net income":"17.43","Income available to com excl extraord":"17.43","Income available to com incl extraord":"17.43","Diluted net income":"17.43","Diluted weighted average shares":"898.82","Diluted eps excluding extraord items":"0.02","Dps - common stock primary issue":"0.00","Diluted normalized eps":"(0.01)","Gain (loss) on sale of assets":"(1.08)"},"Balance sheet":{"Cash":"0.00","Cash & equivalents":"712.05","Short term investments":"97.67","Cash and short term investments":"809.73","Accounts receivable - trade, net":"20.68","Total receivables, net":"75.91","Total inventory":"0.04","Prepaid expenses":"1.03","Other current assets, total":"20.30","Total current assets":"907.00","Property/plant/equipment, total - gross":"48.72","Accumulated depreciation, total":"(36.33)","Property/plant/equipment, total - net":"12.39","Intangibles, net":"198.05","Long term investments":"181.31","Other long term assets, total":"6.46","Total assets":"1,305.21","Accounts payable":"2.55","Accrued expenses":"35.02","Notes payable/short term debt":"5.27","Other current liabilities, total":"34.88","Total current liabilities":"77.73","Long term debt":"0.00","Total long term debt":"0.00","Total debt":"5.27","Minority interest":"4.29","Total liabilities":"82.01","Common stock, total":"898.82","Retained earnings (accumulated deficit)":"426.09","Other equity, total":"(101.71)","Total equity":"1,223.20","Total liabilities & shareholders' equity":"1,305.21","Total common shares outstanding":"898.82","Tangible book value per share, common eq":"1.14","Additional paid-in capital":"1.25","Goodwill, net":"0.23","Note receivable - long term":"0.13"},"Cash flow":{"Cash receipts":"126.11","Cash payments":"(17.65)","Cash taxes paid":"(5.24)","Changes in working capital":"(37.17)","Cash from operating activities":"66.04","Capital expenditures":"(32.54)","Other investing cash flow items, total":"5.10","Cash from investing activities":"(27.45)","Foreign exchange effects":"4.45","Net change in cash":"43.05","Financing cash flow items":"(3.96)","Total cash dividends paid":"(0.00)","Issuance (retirement) of debt, net":"(0.07)","Cash from financing activities":"(4.03)"},"keyMetrics":{"Price and Volume":{"Price closing or last bid":"13.06","52 Week High":"20.80","52 Week Low":"9.45","Pricing date":"","10 Day Average Trading Volume":"19.02","Market Capitalization":"11,738.62","52 Week High Date":"","52 Week Low Date":"","3 Month Average Trading Volume":"344.53","Beta":"1.72","1 Day Price Change":"0.31","13 Week Price Return (Daily)":"19.38","26 Week Price Return (Daily)":"-20.17","5 Day Price Return (Daily)":"2.83","52 Week Price Return (Daily)":"-19.93","Year To Date Price Return (Daily)":"-23.71","Month to Date Price Return (Daily)":"17.24","Price Relative to S&P500 (4 Week)":"-4.67","Price Relative to S&P500 (13 Week)":"-6.15","Price Relative to S&P500 (26 Week)":"-37.47","Price Relative to S&P500 (52 Week)":"-45.58","Price Relative to S&P500 (YTD)":"-41.65"},"Per Share Data":{"EPS excl. Extra Items (Annual)":"0.02","EPS excl. Extra Items (TTM)":"-0.00","EPS Normalized (Annual)":"-0.01","Revenue per Share (Annual)":"0.14","Revenue per Share (TTM)":"0.14","Book Value (Per Share Annual)":"1.36","Book Value (Per Share Quarterly)":"1.29","Tangible Book Value (Per Share Annual)":"1.14","Tangible Book Value (Per Share Quarterly)":"1.07","Cash Per Share (Per Share Annual)":"0.90","Cash Per Share (Per Share Quarterly)":"0.82","Cash Flow (Per Share Annual)":"0.05","Cash Flow (Per Share TTM)":"--","Dividend (Per Share Annual)":"0.00","Dividends (Per Share TTM)":"0.00","EBITD (Per Share TTM)":"-0.03","EPS Basic excl. Extra Items (Annual)":"0.02","EPS Basic excl. Extra Items (TTM)":"-0.00","EPS incl. Extra Items (Annual)":"0.02","EPS incl. Extra Items (TTM)":"-0.00","Free Cash Flow (Per Share TTM)":"0.11","Dividend (Per Share 5Y)":"0.00"},"Valuation":{"P/E excl. Extra Items (Annual)":"673.54","P/E excl. Extra Items (TTM)":"--","P/E Normalized (Annual)":"--","Price to sales (Annual)":"90.36","Price to sales (TTM)":"90.16","Price to Tangible Book (Annual)":"11.45","Price to Tangible Book (Quarterly)":"12.19","Price to Free Cash Flow (Per Share Annual)":"350.40","Price to Cash Flow (Per Share TTM)":"--","Price to Free Cash Flow (Per Share TTM)":"118.52","Price to Book (Annual)":"9.60","Price to Book (Quarterly)":"10.15","P/E Basic excl. Extra Items (TTM)":"--","P/E excl. Extra Items High (TTM)":"3,402.57","P/E excl. Extra Items Low (TTM)":"311.95","P/E incl. Extra Items (TTM)":"--","Net Debt (Interim)":"-741.04","Net Debt (Annual)":"-804.45","Dividend Yield (5Y)":"0.00","Dividend Yield":"--","Current Dividend Yield (TTM)":"0.00"},"Financial Strength":{"Free Cash Flow (Annual)":"33.50","Current Ratio (Annual)":"11.67","Net Interest coverage (Annual)":"--","Long Term Debt/Equity (Annual)":"0.00","Payout Ratio (Annual)":"0.00","Quick Ratio (Annual)":"11.67","Total Debt/Total Equity (Annual)":"0.43","Current EV/Free Cash Flow (Annual)":"713.81","Current EV/Free Cash Flow (TTM)":"--","Current Ratio (Quarterly)":"11.11","Long Term Debt/Equity (Quarterly)":"0.00","Quick Ratio (Quarterly)":"11.11","Total Debt/Total Equity (Quarterly)":"0.00","Free Cash Flow (TTM)":"99.04","Net Interest Coverage (TTM)":"--","Payout Ratio (TTM)":"--"},"Margins":{"Gross Margin (Annual)":"-25.71","Gross Margin (TTM)":"-24.42","Net Profit Margin % (Annual)":"11.93","Net Profit Margin (TTM)":"-4.19","Operating Margin (Annual)":"12.26","Operating Margin (TTM)":"-3.64","Pretax Margin (TTM)":"-3.69","Pretax Margin (Annual)":"12.32","Operating Margin (5Y)":"-11.91","Pretax Margin (5Y)":"-10.82","Free Operating Cash Flow/Revenue (5Y)":"-62.86","Free Operating Cash Flow/Revenue (TTM)":"76.07","Gross Margin (5Y)":"6.84","Net Profit Margin (5Y)":"-18.39"},"Management Effectiveness":{"Return on Assets (Annual)":"1.20","Return on Equity (TTM)":"-0.45","Return on Average Equity (Annual)":"1.43","Return on Average equity (TTM)":"-0.35","Return on Investment (Annual)":"1.27","Return on Investment (TTM)":"-0.47","Return on Average Assets (5Y)":"-2.13","Return on Average Equity (5Y)":"-1.53","Return on Investment (5Y)":"-2.25","Asset Turnover (Annual)":"0.10","Asset Turnover (TTM)":"0.11","Inventory Turnover (Annual)":"3,014.60","Inventory Turnover (TTM)":"3,312.51","Net Income/Employee (Annual)":"13,019.58","Net Income/Employee (TTM)":"-4,713.22","Receivables Turnover (Annual)":"9.20","Receivables Turnover (TTM)":"7.01","Revenue/Employee (Annual)":"109,170.40","Revenue/Employee (TTM)":"112,530.80"},"Growth":{"Revenue Growth (Quarterly YoY)":"1.69","Revenue Growth Rate (5Y)":"-7.81","EPS Growth (Quarterly YoY)":"-43.04","EPS Growth (TTM YoY)":"97.77","EPS Growth Rate (5Y)":"-6.95","Dividend Growth Rate (3Y)":"--","Revenue Growth (TTM YoY)":"29.92","Revenue Growth (Per Share 5Y)":"-7.81","Revenue Growth Rate (3Y)":"-15.70","EPS Growth Rate (3Y)":"-14.64","Book Value Growth Rate (Per Share 5Y)":"-1.37","Tangible Book Value Total Equity CAGR (5Y)":"-3.42","Capital Spending growth rate 5 year":"-6.00","EBITDA CAGR (5Y)":"--","EBITDA Interim CAGR (5Y)":"--","Free Operating Cash Flow CAGR (5Y)":"--","Total Debt CAGR (5Y)":"-26.59","Net Profit Margin Growth Rate (5Y)":"3.77"},"Income Statement":{"Revenue (Annual)":"129.91","Revenue (TTM)":"130.20","EBITD (Annual)":"3.84","EBITD (TTM)":"-25.40","Earnings Before Taxes (Annual)":"16.00","Earnings Before Taxes (TTM)":"-4.80","Net Income to Common (Annual)":"17.43","Net Income to Common (TTM)":"-3.99","Earnings Before Taxes Normalized (Annual)":"-17.83","Net Income Available to Common Normalized (Annual)":"-4.56","Diluted Normalized EPS excl. Extra Items (TTM)":"0.01"}}}